Jennifer Fitzpatrick
Vermogen: - $ op 31-05-2026
Vermogen: - $ op 31-05-2026
Jennifer Fitzpatrick currently works at Sionna Therapeutics, Inc., as Chief Legal Officer from 2025.
Ms. Fitzpatrick also formerly worked at Aegerion Pharmaceuticals, Inc., as Secretary & Director, SAGE Therapeutics, Inc., as Vice President & Corporate Counsel, Revvity, Inc., as Corporate Counsel, and AVEO Pharmaceuticals, Inc., as Corporate Counsel.
Ms. Fitzpatrick received her undergraduate degree from Middlebury College and graduate degree from the University of Virginia School of Law.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 05-03-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| SIONNA THERAPEUTICS, INC. | Algemeen Adviseur | 03-06-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
| REVVITY, INC. | Algemeen Adviseur | - |
| SAGE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| AVEO PHARMACEUTICALS, INC. | Algemeen Adviseur | - |
| AEGERION PHARMACEUTICALS, INC. | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 7 |
|---|---|
Revvity, Inc.
Revvity, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes reagents, analytical instruments and develops software | Health Technology |
Aegerion Pharmaceuticals, Inc.
Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
Middlebury College
Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
SAGE Therapeutics, Inc.
SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
University of Virginia School of Law
University of Virginia School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sionna Therapeutics, Inc.
Sionna Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for CF and rare diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau